Adherex Technologies Inc.

Adherex Technologies Inc.

Adherex Technologies researches and develops cancer treatments. One of its lead drug candidates targets a tumor's blood supply and makes those blood vessels weak and leaky by disrupting a key protein. Other potential therapies could make cancer cells more vulnerable to anti-cancer drugs or help prevent hearing loss in children undergoing certain types of chemotherapy. Adherex Technologies' pipeline is strongly based on compounds that disrupt cadherins, proteins that adhere like molecules together in cell adhesion. Southpoint Capital Advisors own a controlling stake in the company.

Contact Details

Office Address

Adherex Technologies Inc.
501 Eastowne Drive, Suite 140
Chapel Hill, NC, USA 27514
Phone: (919) 636-4530



Robert W. Butts

CEO and Director

Rosty Raykov

Business Reviews for Adherex Technologies Inc.

Related Companies